(Q40902016)

English

Human and mouse Fas (APO-1/CD95) death receptor genes each contain a p53-responsive element that is activated by p53 mutants unable to induce apoptosis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 September 2017

Human and mouse Fas (APO-1/CD95) death receptor genes each contain a p53-responsive element that is activated by p53 mutants unable to induce apoptosis (English)

1 reference

Europe PubMed Central

24 September 2017

author name string

Munsch D

1

1 reference

Europe PubMed Central

24 September 2017

Watanabe-Fukunaga R

2

1 reference

Europe PubMed Central

24 September 2017

Bourdon JC

3

1 reference

Europe PubMed Central

24 September 2017

Nagata S

4

1 reference

Europe PubMed Central

24 September 2017

May E

5

1 reference

Europe PubMed Central

24 September 2017

Yonish-Rouach E

6

1 reference

Europe PubMed Central

24 September 2017

Reisdorf P

7

1 reference

Europe PubMed Central

24 September 2017

language of work or name

0 references

publication date

1 February 2000

1 reference

Europe PubMed Central

24 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

24 September 2017

275

1 reference

Europe PubMed Central

24 September 2017

3867-3872

1 reference

Europe PubMed Central

24 September 2017

6

1 reference

Europe PubMed Central

24 September 2017

p53 function and dysfunction

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

Cancer. p53, guardian of the genome

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

Sequence-specific transcriptional activation is essential for growth suppression by p53.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

Identification of p53 as a sequence-specific DNA-binding protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

Structural aspects of the p53 protein in relation to gene evolution: a second look.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

Definition of a consensus binding site for p53

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

A transcriptionally active DNA-binding site for human p53 protein complexes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

p53 tagged sites from human genomic DNA.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

Radiation-induced cell cycle arrest compromised by p21 deficiency

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

Induction of the growth inhibitor IGF-binding protein 3 by p53

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

A model for p53-induced apoptosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

Bax suppresses tumorigenesis and stimulates apoptosis in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

Bax-deficient mice with lymphoid hyperplasia and male germ cell death

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

Characterization of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

The chromosomal gene structure for murine granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

New yeast-Escherichia coli shuttle vectors constructed with in vitro mutagenized yeast genes lacking six-base pair restriction sites

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

Differential p53 phosphorylation and activation of apoptosis-promoting genes Bax and Fas/APO-1 by irradiation and ara-C treatment

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

Characterization of baculovirus recombinant wild-type p53. Dimerization of p53 is required for high-affinity DNA binding and cysteine oxidation inhibits p53 DNA binding

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

Transcription stimulation of the Fas-encoding gene by nuclear factor for interleukin-6 expression upon influenza virus infection

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

IL-6-regulated transcription factors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3867

21 January 2018

Identifiers

10.1074/JBC.275.6.3867

1 reference

Europe PubMed Central

24 September 2017

1 reference

Europe PubMed Central

24 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40902016&oldid=1909911146"